Rwanda's high-value therapeutic crop (HVTC) initiative is making significant strides, with the medical cannabis off-site infrastructure project now 83 per cent complete, according to the Rwanda Development Board (RDB).
With Rwf2.2 billion allocated for the 2024/2025 fiscal year, the project has already utilized over Rwf1 billion, marking a 46 per cent financial execution rate. RDB officials indicated that the remaining work includes the installation of a double-layered security fence, an essential component to meet international safety standards.
"The overall progress of the work stands at 83%. The remaining tasks include general double-layer fencing. The works related to drainage layout were completed but are yet to be invoiced," Joseph Cedrick Nsengiyumva, RDB's Chief Financial Officer, briefed lawmakers on May 13 during a parliamentary budget hearing.
The cannabis project is part of Rwanda's move into the medical and pharmaceutical industries, with the aim of contributing to global health research and economic diversification. King Kong Organics (KKOG), a subsidiary of KKOG Global, became the first company that secured a five-year license from the Rwanda Development Board (RDB) to operate cannabis production.
Read more at All Africa